30
U.S. Quantitative Research Nomura Securities International, Inc. U.S. Quantitative Research Nomura Global Quantitative Equity Conference in London Natural Selection Natural Selection Joseph Mezrich Please read the analyst certifications and important di l 27 29 l 17 May 2011 Nomura Securities International Inc, New York. Global Quantitative Research disclosures on pp. 27-29. gl

Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

Embed Size (px)

Citation preview

Page 1: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Nomura Securities International, Inc.U.S. Quantitative Research

Nomura Global Quantitative Equity Conference in London

Natural SelectionNatural Selection

Joseph Mezrich Please read the analyst certifications and important di l 27 29 l

17 May 2011

Nomura Securities International Inc, New York.Global Quantitative Research

disclosures on pp. 27-29. gl

Page 2: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Bacteria vs Dinosaurs

• Bacteria are, and always have been, the dominant forms of life on Earth.

• The fossil record of life begins with bacteria.

• Bacteria exist in overwhelming number and unparalleled variety.

• Bacteria inhabit effectively every place suitable for the existence of life.y y p

• Should quantitative investors emulate dinosaurs or bacteria?

2Joseph Mezrich, 212.667.9316, [email protected]

Page 3: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Do quants have ‘dinosaur’ risk?

How do bacteria diversify? Local adaptation to changing environments

Local adaptation = optimizing to a specific (local) objective function

3Joseph Mezrich, 212.667.9316, [email protected]

Page 4: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Outline Examples of structural change in popular factors –Examples of structural change in popular factors

sources of ‘dinosaur’ risk

Selection for different objectives – examples of adaptive investing

• Factor momentum and the success of quants – dinosaurs?

• Low factor volatility and high factor momentum

Risk parity for strategy combination• Risk parity for strategy combination

• Alpha repair – yet another adaptive strategy

4Joseph Mezrich, 212.667.9316, [email protected]

Page 5: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

“Regime change” for factors: Example 1 …Regime change for factors: Example 1 …

350

400

250

300

350

etur

n (%

)

Up-to-down Revisions

100

150

200

lati

ve fa

ctor

re

0

50

100

Cum

u

EBITDA/EV

N t Sh l ti thl t t t d i i d EBITDA/EV i R ll 1000 i F t t

-50

1979

1980

1982

1983

1985

1986

1988

1989

1991

1992

1994

1995

1997

1998

2000

2001

2003

2004

2006

2007

2009

2010

5Joseph Mezrich, 212.667.9316, [email protected]

Notes: Shows cumulative monthly returns to up-to-down revisions and EBITDA/EV in Russell 1000 universe. Factor returns are based on equal-weighted decile spread returns. Analysis ranges from January 1979 through April 2011. Transaction costs are not considered.Source: Nomura Securities International Inc. , Russell. I/B/E/S, Compustat, IDC.

Page 6: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

… Example 2: Accruals still work for high-estimate-dispersion stocks

250

300High estimate dispersion stocksMid estimate dispersion stocksLow estimate dispersion stocks

… Example 2: Accruals still work for high estimate dispersion stocks

200

n to

Acc

rual

(%

)

p

Recession

100

150

umul

ativ

e re

turn

Regulation FD

0

50

8 9 0 1 2 3 4 5 6 7 8 9 0 1 2 3 4 5 6 7 8 9 0

Cu

Regulation FD

1988

1989

1990

1991

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

Note: Universe is Russell 3000. Shows cumulative monthly returns to accruals (equally weighted quintile spread) in each of threegroups categorized by level of dispersion of analyst estimates for current-year earnings (deflated by the absolute value of meanestimate). Accruals are based on Sloan’s (1996) definition using three-month change in trailing four-quarter average in financial statements not using 12-month change in annual financial statements as Sloan originally used Period of analysis is from January

6Joseph Mezrich, 212.667.9316, [email protected]

statements, not using 12-month change in annual financial statements as Sloan originally used. Period of analysis is from January 1989 through March 2011. Transaction costs are not considered.Source: Nomura Securities International Inc., Compustat, IDC, Russell, I/B/E/S, NBER.

Page 7: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

… Example 3: B/P has moved from low beta to no betaa p e 3 / as o ed o o beta to o beta

0 5

0.6B/P- Estimate dispersion

0.2

0.3

0.4

0.5

elat

ion

p

-0.2

-0.1

0

0.1

Rank

Cor

r

-0.4

-0.3

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

B/P-Beta

Note: Shows cross-sectional rank correlations between B/P and beta, and between B/P and estimate dispersion in the Russell 1000 universe. Period of analysis is from July 1984 through February 2011. Source: Nomura Securities International Inc., Russell, Compustat, IDC, I/B/E/S.

7Joseph Mezrich, 212.667.9316, [email protected]

Page 8: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Factor momentum – selection based on return persistence

8Joseph Mezrich, 212.667.9316, [email protected]

Notes: Shows monthly factors (factors are non-sector neutral) selected using the highest factor momentum strategy (60-month) in the Russell 1000. At each point of time, there are three selected factors. The factor labels are sorted according to frequency of selection, with highest frequency at the bottom. Period of analysis are from January 1984 to March 2011.Source: Nomura Securities International Inc., Compustat, I/B/E/S, Russell and IDC

Page 9: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Quant core funds beat fundamental core funds in Q1 2011

Quant vs. Fundamental

Q f d

6

8

%)

+4 bp in YTDQuant core funds

2

4

mul

ativ

e al

pha

(

+151 bp in YTD

0

2

Cu

Dec 2010Fundamental core funds

Notes: Shows cumulative average alpha (relative return to the benchmark) in large-cap core funds based on quantitativemethodologies (dark blue line) and large-cap core funds based on fundamental methodologies (light blue line). Currently, 16

-2

2003 2004 2005 2006 2007 2008 2009 2010 2011

9Joseph Mezrich, 212.667.9316, [email protected]

g ( ) g p g ( g ) yquant core funds and 48 fundamental core funds are in each fund universe. Transaction costs are not considered. Period ofanalysis is from January 2003 through April 2011.Source: Nomura Securities International Inc., Bloomberg, Russell, S&P.

Page 10: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Factor momentum fuels quant core funds

35

408 Cu

Quant fund alpha and factor momentum

Quant core funds

20

25

30

4

6

mulative return ot

core

fund

s (%

)

Aug 2007

0

5

10

15

2

4

of 5yr factor momve

alp

ha o

f qua

n

Five year factor momentum

gQuant meltdown

-15

-10

-5

0

-2

0

mentum

(%)

Cum

ulat

i

Aug 2010Five-year factor momentum

Notes: Shows cumulative average alpha (relative return to the benchmark) of quant core funds (dark blue line) together withcumulative return of five-year factor momentum strategy, where the best five factors (long/short baskets) are owned as long-short positions among our 52 factors based on five-year factor performances in the Russell 1000 universe. Currently, 16 quantcore funds are in the fund universe. Transaction costs are not considered. Period of analysis is from January 2003 through

2003 2004 2005 2006 2007 2008 2009 2010 2011

10Joseph Mezrich, 212.667.9316, [email protected]

core funds are in the fund universe. Transaction costs are not considered. Period of analysis is from January 2003 throughMarch 2011.Source: Nomura Securities International Inc., Bloomberg, Compustat, I/B/E/S, Russell, S&P and IDC.

Page 11: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Factor momentum historically fuels quant core funds

140

160y

(%)

Quant fund alpha and factor momentum

Five-year factor momentum (best 5 factors from 52 factors)

5

10

100

120

140 Cumulative alph

men

tum

str

ateg

y (best 5 factors from 52 factors)

Five-year factor momentum (best 10 factors from 52 factors)

Quant core funds

-5

0

40

60

80

ha of Quant Core

urn

of f

acto

r m

om Aug 2007Quant meltdown

-15

-10

-20

0

20

funds (%)

Cum

ulat

ive

retu

Notes: Shows cumulative average excess return of quant core funds relative to their benchmark (dark blue line) together withcumulative return of five-year factor momentum strategy, where the best five factors (light blue line) or the best 10 factors (dark blueline) are owned as long-short positions among our 52 factors based on five-year factor performances in Russell 1000 universe.C l 16 f d i h f d i T i id d P i d f l i i f J

1520

1989

1990

1991

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

11Joseph Mezrich, 212.667.9316, [email protected]

Currently, 16 quant core funds are in the fund universe. Transaction costs are not considered. Period of analysis is from January1989 through March 2011.Source: Nomura Securities International Inc., Bloomberg, Compustat, I/B/E/S, Russell, S&P and IDC.

Page 12: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Alpha similarities in quant and fundamental core investmentsAlpha similarities in quant and fundamental core investments

0.7Alpha correlation in quant and fundamental core funds

0.5

0.6

elat

ion

Aug 2007Quant meltdown

Quant core funds

0.3

0.4

-yea

r alp

ha c

orre

Fundamental core funds

0.1

0.2

Thre

e-

Notes: Shows three-year alpha correlation in quant core funds (dark blue line) and fundamental core funds (light blue line),where the average of all pairwise alpha correlations are calculated within each fund group. Currently, 16 quant core funds and48 fundamental core funds are in each fund universe Period of analysis is from January 2000 through April 2011

0

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011

12Joseph Mezrich, 212.667.9316, [email protected]

48 fundamental core funds are in each fund universe. Period of analysis is from January 2000 through April 2011.Source: Nomura Securities International Inc., Bloomberg, Russell, S&P.

Page 13: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Factor momentum fuels quant value and growth funds

Quant growth fund alpha and growth-style factor momentum

q g

20

Quant value fund alpha and value-style factor momentum

15

20

25

30

35

10

12

14

16

Cumulative return g

row

th fu

nds

(%)

Growth-style factor momentum

25

30

35

40

12

14

16

18

20

Cumulative return

nt v

alue

fun

ds (

%) Value-style factor momentum

-10

-5

0

5

10

2

4

6

8

n of factor mom

entum

ulat

ive

alph

a of

Qua

nt

Aug 2007Quant meltdown

Quant growth funds10

15

20

25

4

6

8

10

n of factor mom

entum

mul

ativ

e al

pha

of Q

uan

Quant value fundsAug 2007

Quant meltdown

-20

-15

-2

0

2004 2005 2006 2007 2008 2009 2010 2011

m (%

)Cum

uNotes: Left chart shows cumulative average alpha (relative return to the benchmark) of quant value funds (dark blue line) together with cumulative return of five-year value-

0

5

0

2

2004 2005 2006 2007 2008 2009 2010 2011

m (%

)Cum

g p ( ) q ( ) g ystyle factor momentum strategy, where the best five factors are owned as long-short positions among our 34 value-style factors (value, earnings variability, GARP, andothers categories) based on five-year factor performances in Russell 1000. Right chart shows cumulative average alpha (relative return to the benchmark) of quant growthfunds (dark blue line) together with cumulative return of five-year growth-style factor momentum strategy, where the best five factors are owned as long-short positionsamong our 37 growth-style factors (growth, earnings sustainability [flipped polarity for earnings variability], GARP, and others categories) based on five-year factorperformances in Russell 1000. Transaction costs are not considered. Period of analysis is from January 2003 through 20 April 2011.Source: Nomura Securities International Inc., Bloomberg, Compustat, I/B/E/S, Russell, S&P and IDC.

13Joseph Mezrich, 212.667.9316, [email protected]

Page 14: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Alpha diversification among quant styles

16

18Alphas in Quant Core, Value and Growth funds

Quant Core funds

10

12

14

16

nt f

unds

(%

)

Q

Quant Growth funds

Quant Value funds

4

6

8

10

e al

pha

of q

uan

-2

0

2

4

Cum

ulat

ive

Aug 2007Quant meltdown

Notes: Shows cumulative median alpha (relative return to the benchmark) in large-cap core, value, and growth funds based on

-4

2004 2005 2006 2007 2008 2009 2010 2011

14Joseph Mezrich, 212.667.9316, [email protected]

quantitative methodologies. Currently, 16 quant core funds, 6 quant value funds, and 10 quant growth funds are in each funduniverse. Transaction costs are not considered. Period of analysis is from January 2003 through 20 April 2011.Source: Nomura Securities International Inc., Bloomberg, Russell, S&P.

Page 15: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Mood for quants is getting better?

Not only useful for alpha opportunities, quant strategies can provide diversification withdiversification with fundamental investments.

15Source: Pensions & Investments.

Page 16: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Outline : Examples of structural change in popular factors –

sources of ‘dinosaur’ risk

Selection for different objectives – examples of adaptive investing

• Factor momentum and the success of quants – dinosaurs?

• Low factor volatility and high factor momentum

• Risk parity for strategy combination

• Alpha repair – yet another adaptive strategy

16Joseph Mezrich, 212.667.9316, [email protected]

Page 17: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Combinatorics – a cheap approach to factor discoveryCombinatorics a cheap approach to factor discovery

20,000

12,000

16,000bi

nati

ons

4,000

8,000

Com

b

0

3 10 20 30 40 50

Number of factors

Notes: Shows number of combinations to select three factors from a different number of factors.Source: Nomura Securities International Inc.

17Joseph Mezrich, 212.667.9316, [email protected]

Page 18: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Return to low-volatility factor selection strategy

120

140

80

100

120

thly

ret

urns

, %

20

40

60

Cum

ulat

ive

mon

t

-20

0

1980

1981

1982

1983

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

Note: Shows cumulative monthly returns to a strategy of selecting three factors out of 45 factors with the lowest last-one-year return volatilities. Universe isthe Russell 1000. Period of analysis is from January 1980 through end September 2010. Transaction costs are not considered. Past performance shouldnot and cannot be viewed as an indicator of future performance.Source: Nomura Securities International Inc., Compustat, I/B/E/S, Russell, and IDC.

18Joseph Mezrich, 212.667.9316, [email protected]

Page 19: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Three strategies f t t (b t t ) l l tilit d bi tiThree strategies: factor momentum (best returns), low volatility, and combination

300

low volatilities Best Returns combined

150

200

250

hly

ret

urn

s, %

50

100

Cu

mu

lati

ve m

on

t

-50

0

1980

1981

1982

1984

1985

1987

1988

1989

1991

1992

1994

1995

1996

1998

1999

2001

2002

2003

2005

2006

2008

2009

Note: Shows monthly cumulative returns (top chart) and summary (bottom chart) of three strategies: (1) selecting three factors out of 45 with the lowest

low volatility best return combinedAnnualized Return 4.16 8.61 6.39Annualized Volatility 4.88 11.36 6.20Annualized IR 0.85 0.76 1.03

19Joseph Mezrich, 212.667.9316, [email protected]

y ( p ) y ( ) g ( ) g12-month return volatilities, blue line; (2) selecting three factors out of 45 with the best 12-month returns, red line; and 3) investing equally in strategies (1) and (2). Universe is the Russell 1000. Period of analysis is from January 1980 through end September 2010. Factors are constructed sector-neutral. Transaction costs are not considered. Past performance cannot and should not be viewed as indicative of future performance. Source: Nomura Securities International Inc., Compustat, I/B/E/S, Russell, and IDC.

Page 20: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

What gets selected using the low-volatility strategyg g y gy

20Joseph Mezrich, 212.667.9316, [email protected]

Note: Shows monthly factors (sector-neutral) selected using the lowest volatility strategy in the Russell 1000. At each point to time, there are three selectedfactors. The factor labels are sorted according to frequency of selection, with highest frequency at the bottom. Period of analysis is from January 1980through September 2010.Source: Nomura Securities International Inc., Compustat, I/B/E/S, Russell, and IDC.

Page 21: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

What gets selected using the factor-momentum strategyat gets se ected us g t e acto o e tu st ategy

21Joseph Mezrich, 212.667.9316, [email protected]

Note: Shows monthly factors (sector-neutral) selected using the highest factor momentum strategy in the Russell 1000. At each point to time, there are threeselected factors. The factor labels are sorted according to frequency of selection, with highest frequency at the bottom. Period of analysis is from January1980 through September 2010.Source: Nomura Securities International Inc., Compustat, I/B/E/S, Russell, and IDC.

Page 22: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Priced and priceless —plow-volatility and factor-momentum strategies select different types

of factors

68%

77%

%

80%

90%

nfactor momentum low vol

32%40%

50%

60%

70%

ncy

of

sele

ctio

n

32%

23%

0%

10%

20%

30%

Fre

qu

en

Note: Shows frequency of price-related factor and non-price-related factor selection in (1) low-volatility strategy and (2) highest factor-momentum

0%

Non-Price factors Price factors

22Joseph Mezrich, 212.667.9316, [email protected]

Note: Shows frequency of price related factor and non price related factor selection in (1) low volatility strategy and (2) highest factor momentum strategy. Period of analysis is from January 1980 through September 2010. Universe is the Russell 1000.Source: Nomura Securities International Inc., Compustat, I/B/E/S, Russell, and IDC.

Page 23: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Combining strategiesCombining strategies

180

200

220

Factor Momentum

Minimum Variance

Equal Weighted

120

140

160

y R

etur

ns, %

Risk Parity (unlevered)

Risk Parity (levered 1.5X)

80

100

120

Cum

ulat

ive

Mon

thl

20

40

60C

Note: Shows monthly cumulative returns of five strategies: (1) selecting three factors out of 45 with 60-month minimum variance, purple line; (2) selecting three factors out of 45 with the best 60 month returns red line; 3) investing equally in strategies (1) and (2) blue line; 4)

0

Nov

-88

Nov

-89

Nov

-90

Nov

-91

Nov

-92

Nov

-93

Nov

-94

Nov

-95

Nov

-96

Nov

-97

Nov

-98

Nov

-99

Nov

-00

Nov

-01

Nov

-02

Nov

-03

Nov

-04

Nov

-05

Nov

-06

Nov

-07

Nov

-08

Nov

-09

Nov

-10

23Joseph Mezrich, 212.667.9316, [email protected]

(2) selecting three factors out of 45 with the best 60-month returns, red line; 3) investing equally in strategies (1) and (2), blue line; 4) investing in (1) and (2) based on equal risk contribution, green line; 5) 1.5 times leveraged strategy (4), black line. Universe is the Russell 1000. Factors are built non-sector neutral. Period of analysis is from December 1988 through November 2010. Transaction costs are not considered. Past performance cannot and should not be viewed as indicative of future performance. Source: Nomura Securities International Inc., Compustat, I/B/E/S, Russell, and IDC.

Page 24: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Combining strategies via dynamic risk parity weightsCombining strategies via dynamic risk parity weights

Weighted according to Risk Parity (FM: factor momentum; MV: minimum variance)1= 11 + = + = 1

Or write the weights in another way= + = +

Strategy Allocations

min variance (60 m)

best return (60 m) Equal Weighted

Risk Parity Weighting

Risk Parity Weighting (1.5X Levered)

Annualized Return 4.64 7.77 6.21 5.77 8.65Annualized Volatility 6.18 17.78 9.05 6.27 9.41

Note: Shows summaries of five strategies: (1) selecting three factors out of 45 with 60-month minimum variance, purple line; (2) selecting three factors out of 45 with the best 60-month returns, red line; 3) investing equally in strategies (1) and (2), blue line; 4) investing in (1) and (2) based on equal risk contribution, green line; 5) 1.5 times leveraged strategy (4), black line. Universe is the Russell 1000. Factors are built non-sector neutral. Period of analysis is from Dec 1988 through November 2010. Transaction costs are not considered. Past performance cannot and should not be viewed as indicative of future performance

Annualized IR 0.75 0.44 0.69 0.92 0.92

24Joseph Mezrich, 212.667.9316, [email protected]

cannot and should not be viewed as indicative of future performance. Source: Nomura Securities International Inc., Compustat, I/B/E/S, Russell, and IDC.

Page 25: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Alpha Repair – adaptive selection p p p

40

50

60

rns,

%

regression line

US 11.7% absolute return YTD 2011 Outperformed Russell 1000

10

20

30um

ulat

ive

Exce

ss R

etu

Model public

22 Jan 2007,US Alpha Repairmodel published

p81bps in April, 2011and 2.6% YTD 2011annualized outperformance:3.5% since 2007, model public3.3% past 5 yrs4.1% past 10 yrs

-10

0

Jan-

97

Jan-

98

Jan-

99

Jan-

00

Jan-

01

Jan-

02

Jan-

03

Jan-

04

Jan-

05

Jan-

06

Jan-

07

Jan-

08

Jan-

09

Jan-

10

Jan-

11

Cu model published

120

(%)_

60

80

100

retu

rn o

ver N

OM

UR

A 4

00 (

Model public

Regression line

JapanOutperformed NOMURA 40056 bp in April 20111.7 % in YTD 2011annualized outperformance:10.4 % since 2008, model public

0

20

40ec

-99

un-0

0

ec-0

0

un-0

1

ec-0

1

un-0

2

ec-0

2

un-0

3

ec-0

3

un-0

4

ec-0

4

un-0

5

ec-0

5

un-0

6

ec-0

6

un-0

7

ec-0

7

un-0

8

ec-0

8

un-0

9

ec-0

9

un-1

0

ec-1

0

Cum

ulat

ive

exce

ss

12 Sep 2008,Japan Alpha Repairmodel published

9.8 % past 5 yrs9.7% past 10 yrs

25

Notes: Shows cumulative monthly excess returns of Alpha Repair portfolios for U.S. and Japan. Past model performance should not and cannot be viewed as indicative of future performance; complete details available upon request. Transaction costs are not considered.Source: Nomura Securities International Inc., Compustat, I/B/E/S, IDC, Russell.

De Ju De Ju De Ju De Ju De Ju De Ju De Ju De Ju De Ju De Ju De Ju De

Page 26: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Alpha Repair – uncorrelated with other quant fundsp p q

0.6Alpha correlation in quant core funds and US alpha repair

Aug 2007

0.3

0.4

0.5

lati

on

Quant meltdownWithin Quant core funds

0.1

0.2

0.3

year

alp

ha c

orre

Between US alpha repair and Quant core funds

-0.2

-0.1

0

Thre

e-y

Notes: Shows three-year alpha correlation in quant core funds (dark blue line) and alpha correlation between quant core fundsand US alpha repair (red line), where the average of all pairwise alpha correlations are calculated in quant core funds.

-0.3

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011

26

p p ( ) g p p qCurrently, 16 quant core funds and 48 fundamental core funds are in each fund universe. Period of analysis is from January2000 through April 2011.Source: Nomura Securities International Inc., Russell, S&P, Compustat, I/B/E/S, IDC, Bloomberg.

Page 27: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

Any Authors named on this report are Research Analysts unless otherwise indicatedy p y

Analyst CertificationI, Joseph Mezrich, hereby certify (1) that the views expressed in this Research report accurately reflect my personal views about any or all of the subject securities or issuers referred to in this Research report, (2) no part of my compensation was, is or will be directly or indirectly related to the specific recommendations or views expressed in this Research report and (3) no part of my compensation is tied to any specific investment banking transactions performed by Nomura Securities International, Inc., Nomura International plc or any other Nomura Group company.

Conflict-of-interest disclosuresImportant disclosures may be accessed through the following website: http://www.nomura.com/research/pages/disclosures/disclosures.aspx . If you have difficulty with this site or you do not have a password, please contact your Nomura Securities International, Inc. salesperson (1-877-865-5752) or email [email protected] for assistance.

Online availability of research and additional conflict-of-interest disclosuresNomura Japanese Equity Research is available electronically for clients in the US on NOMURA.COM, REUTERS, BLOOMBERG and THOMSON ONE ANALYTICS. For clients in Europe, Japan and elsewhere in Asia it is available on NOMURA.COM, REUTERS and BLOOMBERG.Important disclosures may be accessed through the left hand side of the Nomura Disclosure web page http://www.nomura.com/research or requested from Nomura Securities International, Inc., on 1-877-865-5752. If you have any difficulties with the website, please email [email protected] for technical assistance.

The analysts responsible for preparing this report have received compensation based upon various factors including the firm's total revenues, a portion of which is generated by Investment Banking activities.

Industry Specialists identified in some Nomura International plc research reports are employees within the Firm who are responsible for the sales and trading effort in the sector for which they have coverage. Industry Specialists do not contribute in any manner to the content of research reports in which their names appear.Marketing Analysts identified in some Nomura research reports are research analysts employed by Nomura International plc who are primarily responsible for marketing Nomura’s Equity Research product in the sector for which they have coverage. Marketing Analysts may also contribute to research reports in which their names appear and publish research on their sector.

DisclaimersThis publication contains material that has been prepared by the Nomura entity identified at the top or bottom of page 1 herein, if any, and/or, with the sole or joint contributions of one or more Nomura entities whose employees and their respective affiliations are specified on page 1 herein or elsewhere identified in the publication. Affiliates and subsidiaries of Nomura Holdings Inc (collectively the 'Nomura Group') include: Nomura Securities Co Ltd ('NSC') Tokyo Japan; Nomura International plc ('NIplc') United Kingdom; Nomura SecuritiesHoldings, Inc. (collectively, the Nomura Group ), include: Nomura Securities Co., Ltd. ( NSC ) Tokyo, Japan; Nomura International plc ( NIplc ), United Kingdom; Nomura Securities International, Inc. ('NSI'), New York, NY; Nomura International (Hong Kong) Ltd. (‘NIHK’), Hong Kong; Nomura Financial Investment (Korea) Co., Ltd. (‘NFIK’), Korea (Information on Nomura analysts registered with the Korea Financial Investment Association ('KOFIA') can be found on the KOFIA Intranet at http://dis.kofia.or.kr ); Nomura Singapore Ltd. (‘NSL’), Singapore (Registration number 197201440E, regulated by the Monetary Authority of Singapore); Capital Nomura Securities Public Company Limited (‘CNS’), Thailand; Nomura Australia Ltd. (‘NAL’), Australia (ABN 48 003 032 513), regulated by the Australian Securities and Investment Commission ('ASIC') and holder of an Australian financial services licence number 246412; P.T. Nomura Indonesia (‘PTNI’), Indonesia; Nomura Securities Malaysia Sdn. Bhd. (‘NSM’), Malaysia; Nomura International (Hong Kong) Ltd., Taipei Branch (‘NITB’), Taiwan; Nomura Financial Advisory and Securities (India) Private Limited (‘NFASL’), Mumbai, India (Registered Address: Ceejay House, Level 11, Plot F, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai- 400 018, India; SEBI Registration No: BSE INB011299030, NSE INB231299034, INF231299034, INE 231299034).

27Joseph Mezrich, 212.667.9316, [email protected]

Page 28: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

THIS MATERIAL IS: (I) FOR YOUR PRIVATE INFORMATION, AND WE ARE NOT SOLICITING ANY ACTION BASED UPON IT; (II) NOT TO BE CONSTRUED AS AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITY IN ANY JURISDICTION WHERE SUCH OFFER OR SOLICITATION WOULD BE ILLEGAL; AND (III) BASED UPON ( )INFORMATION THAT WE CONSIDER RELIABLE.

NOMURA GROUP DOES NOT WARRANT OR REPRESENT THAT THE PUBLICATION IS ACCURATE, COMPLETE, RELIABLE, FIT FOR ANY PARTICULAR PURPOSE OR MERCHANTABLE AND DOES NOT ACCEPT LIABILITY FOR ANY ACT (OR DECISION NOT TO ACT) RESULTING FROM USE OF THIS PUBLICATION AND RELATED DATA. TO THE MAXIMUM EXTENT PERMISSIBLE ALL WARRANTIES AND OTHER ASSURANCES BY NOMURA GROUP ARE HEREBY EXCLUDED AND NOMURA GROUP SHALL HAVE NO LIABILITY FOR THE USE, MISUSE, OR DISTRIBUTION OF THIS INFORMATION.

Opinions expressed are current opinions as of the original publication date appearing on this material only and the information, including the opinions contained herein, are subject to change without notice. Nomura is under no duty to update this publication. If and as applicable, NSI's investment banking relationships, investment banking and non-investment banking compensation and securities ownership (identified in this report as 'Disclosures Required in the United States'), if any, are specified in disclaimers and related disclosures in this report. In addition, other members of the Nomura Group may from time to time perform investment banking or other services (including acting as advisor, manager or lender) for, or solicit investment banking or other business from, companies mentioned herein. Furthermore, the Nomura Group, and/or its officers, directors and employees, including persons, without limitation, involved in the preparation or issuance of this material may, to the extent permitted by applicable law and/or regulation, have long or short positions in, and buy or sell, the securities (including ownership by NSI, referenced above), or derivatives (including options) thereof, of companies mentioned herein, or related securities or derivatives. For financial instruments admitted to trading on an EU regulated market, Nomura Holdings Inc's affiliate or its subsidiary companies may act as market maker or liquidity provider (in accordance with the interpretation of these definitions under FSA rules in the UK) in the financial instruments of the issuer. Where the activity of liquidity provider is carried out in accordance with the definition given to it by specific laws and regulations of other EU jurisdictions, this will be separately disclosed within this report. Furthermore, the Nomura Group may buy and sell certain of the securities of companies mentioned herein, as agent for its clients.

Investors should consider this report as only a single factor in making their investment decision and, as such, the report should not be viewed as identifying or suggesting all risks, direct or indirect, that may be associated with any investment decision. Please see the further disclaimers in the disclosure information on companies covered by Nomura analysts available at www.nomura.com/research under the 'Disclosure' tab. Nomura Group produces a number of different types of research product including, among others, fundamental analysis, quantitative analysis and short term trading ideas; recommendations contained in one type of research product may differ from recommendations contained in other types of research product, whether as a result of differing time horizons, methodologies or otherwise; it is possible that individual employees of Nomura may have different perspectives to this publication.

NSC and other non-US members of the Nomura Group (i.e. excluding NSI), their officers, directors and employees may, to the extent it relates to non-US issuers and is permitted by applicable law, have acted upon or used this material prior to, or immediately following, its publication.

Foreign-currency-denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of, or income derived from, the investment. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies, effectively assume currency risk.

The securities described herein may not have been registered under the US Securities Act of 1933, and, in such case, may not be offered or sold in the United States or to US persons unless they have been registered under such Act, or except in compliance with an exemption from the registration requirements of such Act. Unless governing law permits otherwise, you must contact a Nomura entity in your home jurisdiction if you want to use our services in effecting a transaction in the securities mentioned in this material.

This publication has been approved for distribution in the United Kingdom and European Union as investment research by NIplc, which is authorized and regulated by the UK Financial Services Authority ('FSA') and is a member of the London Stock Exchange. It does not constitute a personal recommendation, as defined by the FSA, or take into account the particular investment objectives, financial situations, or needs of individual investors. It is intended only for investors who are 'eligible counterparties' or 'professional clients' as defined by the FSA, and may not, therefore, be redistributed to retail clients as defined by the FSA. This publication may be distributed in Germany via Nomura Bank (Deutschland) GmbH, which is authorized and regulated in Germany by the Federal Financial Supervisory Authority ('BaFin'). This publication has been approved by NIHK, which is regulated by the Hong Kong Securities and Futures Commission, for distribution in Hong Kong by NIHK. This publication has been approved for distribution in Australia by NAL, which is authorized and regulated in Australia by the ASIC. This publication has also been approved for distribution in Malaysia by NSM. In Singapore, this publication has been distributed by NSL. NSL accepts legal responsibility for the content of this publication where it concerns securities futures and foreign exchange issued by their foreign affiliates in respect of recipients who are not accredited expert or

28Joseph Mezrich, 212.667.9316, [email protected]

content of this publication, where it concerns securities, futures and foreign exchange, issued by their foreign affiliates in respect of recipients who are not accredited, expert or institutional investors as defined by the Securities and Futures Act (Chapter 289). Recipients of this publication should contact NSL in respect of matters arising from, or in connection with, this publication. Unless prohibited by the provisions of Regulation S of the U.S. Securities Act of 1933, this material is distributed in the United States, by NSI, a US-registered broker-dealer, which accepts responsibility for its contents in accordance with the provisions of Rule 15a-6, under the US Securities Exchange Act of 1934.

Page 29: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

This publication has not been approved for distribution in the Kingdom of Saudi Arabia or to clients other than 'professional clients' in the United Arab Emirates by Nomura Saudi Arabia, NIplc or any other member of the Nomura Group, as the case may be. Neither this publication nor any copy thereof may be taken or transmitted or distributed, directly or indirectly, by any person other than those authorised to do so into the Kingdom of Saudi Arabia or in the United Arab Emirates or to any person located in the Kingdom of Saudi Arabia or to clients other p g y p gthan 'professional clients' in the United Arab Emirates. By accepting to receive this publication, you represent that you are not located in the Kingdom of Saudi Arabia or that you are a 'professional client' in the United Arab Emirates and agree to comply with these restrictions. Any failure to comply with these restrictions may constitute a violation of the laws of the Kingdom of Saudi Arabia or the United Arab Emirates.

No part of this material may be (i) copied, photocopied, or duplicated in any form, by any means; or (ii) redistributed without the prior written consent of the Nomura Group member identified in the banner on page 1 of this report. Further information on any of the securities mentioned herein may be obtained upon request. If this publication has been distributed by electronic transmission, such as e-mail, then such transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of this publication, which may arise as a result of electronic transmission If verification is required please request a hard copy versiontransmission. If verification is required, please request a hard-copy version.

Additional information available upon requestNIPlc and other Nomura Group entities manage conflicts identified through the following: their Chinese Wall, confidentiality and independence policies, maintenance of a Restricted List and a Watch List, personal account dealing rules, policies and procedures for managing conflicts of interest arising from the allocation and pricing of securities and impartial investment research and disclosure to clients via client documentation.

Disclosure information is available at the Nomura Disclosure web page:http://www nomura com/research/pages/disclosures/disclosures aspxhttp://www.nomura.com/research/pages/disclosures/disclosures.aspx

29Joseph Mezrich, 212.667.9316, [email protected]

Page 30: Nomura Securities International, Inc. U.S. Quantitative ... · U.S. Quantitative Research Bacteria vs Dinosaurs • Bacteria are, and always have been, the dominant forms of life

U.S. Quantitative Research

30Joseph Mezrich, 212.667.9316, [email protected]